Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients

Glenn M. Chertow, D. Jordi Goldstein-Fuchs, J. Michael Lazarus, George A. Kaysen

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background. Prealbumin (transthyretin) is a hepatic secretory protein thought to be important in the evaluation of nutritional deficiency and nutrition support. Prior studies have suggested that the serum prealbumin concentration is independently associated with mortality in hemodialysis patients, even with adjustment for serum albumin and other nutritional parameters. Methods. To determine whether prealbumin was independently associated with mortality and morbidity (cause-specific hospitalization) in hemodialysis patients, we analyzed data on 7815 hemodialysis patients with at least one determination of serum prealbumin during the last three months of 1997. Unadjusted, case mix-adjusted, and multivariable-adjusted relative risks of death were calculated for categories of serum prealbumin using proportional hazards regression. We also determined whether the prealbumin concentration was associated with all-cause, cardiovascular, infection-related, and vascular access-related hospitalization. Results. The relative risk (RR) of death was inversely related to the serum prealbumin concentration. Relative to prealbumin ≥40 mg/dL, the adjusted RRs of death were 2.41, 1.85, 1.49, and 1.23 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of hospitalization due to infection were 2.97, 1.95, 1.81, and 1.61 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of vascular access-related hospitalization were 0.48, 0.52, 0.58, and 0.71 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. While serum albumin was strongly associated with mortality and all-cause hospitalization, it was not associated with hospitalization due to infection, and lower levels were associated with higher rather than lower rates of vascular access-related hospitalization. Conclusion. In hemodialysis patients, lower prealbumin concentrations were associated with mortality and hospitalization due to infection, independent of serum albumin and other clinical characteristics. Higher prealbumin concentrations were associated with vascular access-related hospitalization. In light of these findings, more intensive study into the determinants and biological actions of prealbumin (transthyretin) in end-stage renal disease is warranted.

Original languageEnglish (US)
Pages (from-to)2794-2800
Number of pages7
JournalKidney International
Volume68
Issue number6
DOIs
StatePublished - Dec 2005

Fingerprint

Prealbumin
Renal Dialysis
Hospitalization
Mortality
Blood Vessels
Serum Albumin
Serum
Cardiovascular Infections
Infection
Diagnosis-Related Groups

Keywords

  • Dialysis
  • Epidemiology
  • Infection
  • Mortality
  • Prealbumin
  • Vascular access

ASJC Scopus subject areas

  • Nephrology

Cite this

Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. / Chertow, Glenn M.; Goldstein-Fuchs, D. Jordi; Lazarus, J. Michael; Kaysen, George A.

In: Kidney International, Vol. 68, No. 6, 12.2005, p. 2794-2800.

Research output: Contribution to journalArticle

Chertow, Glenn M. ; Goldstein-Fuchs, D. Jordi ; Lazarus, J. Michael ; Kaysen, George A. / Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. In: Kidney International. 2005 ; Vol. 68, No. 6. pp. 2794-2800.
@article{2af2180f84da4cb8b71b9a5f6aec04e5,
title = "Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients",
abstract = "Background. Prealbumin (transthyretin) is a hepatic secretory protein thought to be important in the evaluation of nutritional deficiency and nutrition support. Prior studies have suggested that the serum prealbumin concentration is independently associated with mortality in hemodialysis patients, even with adjustment for serum albumin and other nutritional parameters. Methods. To determine whether prealbumin was independently associated with mortality and morbidity (cause-specific hospitalization) in hemodialysis patients, we analyzed data on 7815 hemodialysis patients with at least one determination of serum prealbumin during the last three months of 1997. Unadjusted, case mix-adjusted, and multivariable-adjusted relative risks of death were calculated for categories of serum prealbumin using proportional hazards regression. We also determined whether the prealbumin concentration was associated with all-cause, cardiovascular, infection-related, and vascular access-related hospitalization. Results. The relative risk (RR) of death was inversely related to the serum prealbumin concentration. Relative to prealbumin ≥40 mg/dL, the adjusted RRs of death were 2.41, 1.85, 1.49, and 1.23 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of hospitalization due to infection were 2.97, 1.95, 1.81, and 1.61 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of vascular access-related hospitalization were 0.48, 0.52, 0.58, and 0.71 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. While serum albumin was strongly associated with mortality and all-cause hospitalization, it was not associated with hospitalization due to infection, and lower levels were associated with higher rather than lower rates of vascular access-related hospitalization. Conclusion. In hemodialysis patients, lower prealbumin concentrations were associated with mortality and hospitalization due to infection, independent of serum albumin and other clinical characteristics. Higher prealbumin concentrations were associated with vascular access-related hospitalization. In light of these findings, more intensive study into the determinants and biological actions of prealbumin (transthyretin) in end-stage renal disease is warranted.",
keywords = "Dialysis, Epidemiology, Infection, Mortality, Prealbumin, Vascular access",
author = "Chertow, {Glenn M.} and Goldstein-Fuchs, {D. Jordi} and Lazarus, {J. Michael} and Kaysen, {George A.}",
year = "2005",
month = "12",
doi = "10.1111/j.1523-1755.2005.00751.x",
language = "English (US)",
volume = "68",
pages = "2794--2800",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients

AU - Chertow, Glenn M.

AU - Goldstein-Fuchs, D. Jordi

AU - Lazarus, J. Michael

AU - Kaysen, George A.

PY - 2005/12

Y1 - 2005/12

N2 - Background. Prealbumin (transthyretin) is a hepatic secretory protein thought to be important in the evaluation of nutritional deficiency and nutrition support. Prior studies have suggested that the serum prealbumin concentration is independently associated with mortality in hemodialysis patients, even with adjustment for serum albumin and other nutritional parameters. Methods. To determine whether prealbumin was independently associated with mortality and morbidity (cause-specific hospitalization) in hemodialysis patients, we analyzed data on 7815 hemodialysis patients with at least one determination of serum prealbumin during the last three months of 1997. Unadjusted, case mix-adjusted, and multivariable-adjusted relative risks of death were calculated for categories of serum prealbumin using proportional hazards regression. We also determined whether the prealbumin concentration was associated with all-cause, cardiovascular, infection-related, and vascular access-related hospitalization. Results. The relative risk (RR) of death was inversely related to the serum prealbumin concentration. Relative to prealbumin ≥40 mg/dL, the adjusted RRs of death were 2.41, 1.85, 1.49, and 1.23 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of hospitalization due to infection were 2.97, 1.95, 1.81, and 1.61 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of vascular access-related hospitalization were 0.48, 0.52, 0.58, and 0.71 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. While serum albumin was strongly associated with mortality and all-cause hospitalization, it was not associated with hospitalization due to infection, and lower levels were associated with higher rather than lower rates of vascular access-related hospitalization. Conclusion. In hemodialysis patients, lower prealbumin concentrations were associated with mortality and hospitalization due to infection, independent of serum albumin and other clinical characteristics. Higher prealbumin concentrations were associated with vascular access-related hospitalization. In light of these findings, more intensive study into the determinants and biological actions of prealbumin (transthyretin) in end-stage renal disease is warranted.

AB - Background. Prealbumin (transthyretin) is a hepatic secretory protein thought to be important in the evaluation of nutritional deficiency and nutrition support. Prior studies have suggested that the serum prealbumin concentration is independently associated with mortality in hemodialysis patients, even with adjustment for serum albumin and other nutritional parameters. Methods. To determine whether prealbumin was independently associated with mortality and morbidity (cause-specific hospitalization) in hemodialysis patients, we analyzed data on 7815 hemodialysis patients with at least one determination of serum prealbumin during the last three months of 1997. Unadjusted, case mix-adjusted, and multivariable-adjusted relative risks of death were calculated for categories of serum prealbumin using proportional hazards regression. We also determined whether the prealbumin concentration was associated with all-cause, cardiovascular, infection-related, and vascular access-related hospitalization. Results. The relative risk (RR) of death was inversely related to the serum prealbumin concentration. Relative to prealbumin ≥40 mg/dL, the adjusted RRs of death were 2.41, 1.85, 1.49, and 1.23 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of hospitalization due to infection were 2.97, 1.95, 1.81, and 1.61 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. The adjusted RRs of vascular access-related hospitalization were 0.48, 0.52, 0.58, and 0.71 for prealbumin <15, 15-20, 20-25, and 25-30 mg/dL, respectively. While serum albumin was strongly associated with mortality and all-cause hospitalization, it was not associated with hospitalization due to infection, and lower levels were associated with higher rather than lower rates of vascular access-related hospitalization. Conclusion. In hemodialysis patients, lower prealbumin concentrations were associated with mortality and hospitalization due to infection, independent of serum albumin and other clinical characteristics. Higher prealbumin concentrations were associated with vascular access-related hospitalization. In light of these findings, more intensive study into the determinants and biological actions of prealbumin (transthyretin) in end-stage renal disease is warranted.

KW - Dialysis

KW - Epidemiology

KW - Infection

KW - Mortality

KW - Prealbumin

KW - Vascular access

UR - http://www.scopus.com/inward/record.url?scp=32844457304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32844457304&partnerID=8YFLogxK

U2 - 10.1111/j.1523-1755.2005.00751.x

DO - 10.1111/j.1523-1755.2005.00751.x

M3 - Article

C2 - 16316355

AN - SCOPUS:32844457304

VL - 68

SP - 2794

EP - 2800

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 6

ER -